Dr. Edwin Pascal Alyea III, M.D.
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- Duke University School of Medicine (1989)
- Years since graduation
- 37
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 20
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1989Medical school: Duke University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
MA license 74343
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Duke University Hospital Durham, NC
Medical groups
- Duke Health Integrated Practice, Inc (3,185 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 20
- Services billed
- 98
- Patients’ average age
- 65
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 56 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 2 companies reported 11 payments worth $9,770 in total to this clinician.
| AstraZeneca UK Limited | $7,370 |
|---|---|
| National Marrow Donor Program | $2,400 |
| Consulting Fee | $9,770 |
|---|
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca UK Limited Jan 14, 2025 | Consulting Fee CALQUENCE · Oncology | $2,640 |
| AstraZeneca UK Limited Jan 21, 2025 | Consulting Fee CALQUENCE · Oncology | $1,705 |
| AstraZeneca UK Limited Sep 16, 2025 | Consulting Fee CALQUENCE · Oncology | $1,485 |
| National Marrow Donor Program Jan 17, 2025 | Consulting Fee | $1,200 |
| AstraZeneca UK Limited Dec 16, 2025 | Consulting Fee CALQUENCE · Oncology | $605 |
| National Marrow Donor Program May 23, 2025 | Consulting Fee | $600 |
| National Marrow Donor Program Oct 24, 2025 | Consulting Fee | $600 |
| AstraZeneca UK Limited Apr 15, 2025 | Consulting Fee CALQUENCE · Oncology | $385 |
| AstraZeneca UK Limited Mar 18, 2025 | Consulting Fee CALQUENCE · Oncology | $275 |
| AstraZeneca UK Limited Feb 25, 2025 | Consulting Fee CALQUENCE · Oncology | $220 |
All 11 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca UK Limited Dec 16, 2025 | Consulting Fee CALQUENCE · Oncology | $605 |
| National Marrow Donor Program Oct 24, 2025 | Consulting Fee | $600 |
| AstraZeneca UK Limited Sep 16, 2025 | Consulting Fee CALQUENCE · Oncology | $1,485 |
| AstraZeneca UK Limited Aug 19, 2025 | Consulting Fee CALQUENCE · Oncology | $55.00 |
| National Marrow Donor Program May 23, 2025 | Consulting Fee | $600 |
| AstraZeneca UK Limited Apr 15, 2025 | Consulting Fee CALQUENCE · Oncology | $385 |
| AstraZeneca UK Limited Mar 18, 2025 | Consulting Fee CALQUENCE · Oncology | $275 |
| AstraZeneca UK Limited Feb 25, 2025 | Consulting Fee CALQUENCE · Oncology | $220 |
| AstraZeneca UK Limited Jan 21, 2025 | Consulting Fee CALQUENCE · Oncology | $1,705 |
| National Marrow Donor Program Jan 17, 2025 | Consulting Fee | $1,200 |
| AstraZeneca UK Limited Jan 14, 2025 | Consulting Fee CALQUENCE · Oncology | $2,640 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.